Frontlight ResearchEarly access
Idiopathic pulmonary fibrosis trials in China
20 of 26 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ChinaA Multicenter, Randomized, Blinded, Placebo- and Active-Controlled Phase II Study to Evaluate the Efficacy and Safety of SYH9061 in Adult Patients With Idiopathic Pulmonary Fibrosis
- Where
- Guangzhou
- Age
- 40 years and over
- People
- 300
- Run by
- CSPC-NBP Pharmaceutical Co., Ltd.
See details and how to joinNCT07933133 - Phase 2Enrolling by invitationA Phase Ⅱa Study of ND-003 Tablets in Patients With Idiopathic Pulmonary Fibrosis
- Where
- Guangzhou
- Age
- 40 years and over
- People
- 10
- Run by
- Shenzhen NewDEL Biotech, Co., Ltd
See details and how to joinNCT07929948 - Phase 2Not yet taking people in ChinaA Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary Fibrosis
- Where
- Changsha, Shanghai
- Age
- 40 years to 80 years
- People
- 75
- Run by
- Shanghai Huaota Biopharmaceutical Co., Ltd.
See details and how to joinNCT07909655 - Phase 3Not yet taking people in ChinaLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Hohhot, Lanzhou, Nanjing, Ningbo, Shandong, Shanghai, Shanghai Shi, Shenyang, Shenzhen, Shenzhen Shi, Shijiazhuang, Suzhou, Tianjin, Wuhan, Wuxi, Xi'an, Xuzhou, Yichang Shi, Yinchuan, Zhengzhou
- Age
- 18 years and over
- People
- 2,380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - Phase 2Taking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Beijing, Changchun, Changsha, Chengdu, Guangzhou, Lanzhou, Nanchang, Nanjing, Shanghai, Shenyang, Wuhan, Xuzhou, Zhengzhou
- Age
- 40 years and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - No phaseTaking peopleJin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF
- Where
- Zhengzhou
- Age
- 40 years to 85 years
- People
- 384
- Run by
- Henan University of Traditional Chinese Medicine
See details and how to joinNCT06914713 - Phase 3Taking peopleStudy Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Anyang, Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei, Hohhot, Jiaxing, Jinan, Kunming, Nanchang, Nanjing, Nanning, Nanyang, Ningbo, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Ürümqi, Wenzhou, Wuhan, Xiamen, Xi'an, Xuzhou, Yichang, Yuncheng, Zhengzhou
- Age
- 40 years and over
- People
- 320
- Run by
- InSilico Medicine Hong Kong Limited
See details and how to joinNCT07687459 - No phaseTaking peopleDaoyin Technique for Improving Exercise Endurance in IPF
- Where
- Beijing, Shenyang, Zhengzhou
- Age
- 40 years to 85 years
- People
- 236
- Run by
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
See details and how to joinNCT07019714 - Early phase 1Taking peopleA Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
- Where
- Shanghai
- Age
- 18 years to 45 years
- People
- 53
- Run by
- Shanghai Synvida Biotechnology Co.,Ltd.
See details and how to joinNCT06267183 - Phase 3Not yet taking people in ChinaA Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis
- Where
- Beijing
- Age
- 40 years and over
- People
- 263
- Run by
- Shanghai Ark Biopharmaceutical Co., Ltd.
See details and how to joinNCT07719023 - Phase 2Taking peoplePhase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis
- Where
- Shanghai
- Age
- 40 years and over
- People
- 96
- Run by
- Dragonboat Biopharmaceutical Company Limited
See details and how to joinNCT07447102 - Phase 2Taking peopleA Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients
- Where
- Beijing
- Age
- 18 years and over
- People
- 110
- Run by
- Sunshine Lake Pharma Co., Ltd.
See details and how to joinNCT05139719 - Phase 3Taking peopleConfirmatory Clinical Study of HEC585 Tablets in Patients With IPF
- Where
- Beijing
- Age
- 40 years to 80 years
- People
- 472
- Run by
- Sunshine Lake Pharma Co., Ltd.
See details and how to joinNCT07082842 - Phase 1Not yet taking people in ChinaSafety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 9
- Run by
- Huan Ye
See details and how to joinNCT07515066 - Phase 3Taking peopleA Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Beijing
- Age
- 40 years to 80 years
- People
- 508
- Run by
- Beijing Tide Pharmaceutical Co., Ltd
See details and how to joinNCT07464912 - Phase 2Taking peopleA Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis
- Where
- Chengdu, Guangzhou, Hangzhou, Nanchang, Nanjing, Neimeng, Shanghai, Tianjin, Xuzhou, Zhengzhou
- Age
- 40 years and over
- People
- 48
- Run by
- Shanghai Synvida Biotechnology Co.,Ltd.
See details and how to joinNCT07121413 - Early phase 1Not yet taking people in ChinaTreatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy
- Where
- Yiwu
- Age
- 40 years to 80 years
- People
- 12
- Run by
- Regend Therapeutics
See details and how to joinNCT07359963 - Phase 2Not yet taking people in ChinaMenstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis
- Where
- Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hebei, Nanjing, Shanghai, Shenzhen, Tianjin, Wuhan, Xi’an, Xuzhou, Yinchuan, Zhengzhou
- Age
- 18 years to 80 years
- People
- 66
- Run by
- Ruijin Hospital
See details and how to joinNCT07131150 - No phaseTaking peopleApplication of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 100
- Run by
- China-Japan Friendship Hospital
See details and how to joinNCT06251687 - Phase 2/3Taking peopleSC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Beijing
- Age
- 40 years to 80 years
- People
- 210
- Run by
- Guangzhou JOYO Pharma Co., Ltd
See details and how to joinNCT06125327